Seelos Therapeutics

SEELQ · OTC

$0.00−$0.0001 (−90.00%)TodayMarket open · · Delayed 15 min
No price history for this range.

About SEELQ

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The company is headquartered in New York City, New York and currently employs 8 full-time employees. The company has filed a voluntary petition under chapter 11 of Title 11 of the United States Code in the United States Bankruptcy Court for the Southern District of New York.

Employees
8
Headquarters
New York City, New York
Listed
Oct 27, 1993
Sector
Health Care
Industry
Pharmaceuticals

SEELQ key statistics

Market cap
14
Price-earnings ratio
0.00
Dividend yield
—
Average volume
590
Volume
22
Open price
$0.00
High today
$0.00
Low today
$0.00
52 Week high
$0.01
52 Week low
$0.00

Seelos Therapeutics (SEELQ) at a glance

As of Oct 19, 2026, Seelos Therapeutics (SEELQ) shares are priced at $0.00, giving the company a market cap of 14 and a price-to-earnings ratio of 0.00.

Volume so far is 22 shares, below the average of 590 shares a day.

Over the past year Seelos Therapeutics has ranged from $0.00 to $0.01, and now sits 0% of the way up that range.

Seelos Therapeutics met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q4 FY23 it reported -$101.12 per share against an estimate of -$105.47.

SEELQ earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 8 quarters, by 17.0% on average.

  1. Q1 FY22: reported -$499.20 per share against an estimate of -$711.94
  2. Q2 FY22: reported -$768.00 per share against an estimate of -$566.90
  3. Q3 FY22: reported -$691.20 per share against an estimate of -$415.30
  4. Q4 FY22: reported -$652.80 per share against an estimate of -$514.18
  5. Q1 FY23: reported -$460.80 per share against an estimate of -$435.07
  6. Q2 FY23: reported -$844.80 per share against an estimate of -$369.14
  7. Q3 FY23: reported -$460.80 per share against an estimate of -$237.31
  8. Q4 FY23: reported -$101.12 per share against an estimate of -$105.47

Similar companies

Companies in the same industry as Seelos Therapeutics

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.